Fate therapeutics to webcast conference call reporting first quarter 2022 financial results

San diego, april 22, 2022 (globe newswire) -- fate therapeutics, inc. (the “company” or “fate therapeutics”) (nasdaq: fate), a clinical-stage biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for patients with cancer, today announced that the company will host a conference call and live audio webcast on wednesday, may 4, 2022 at 5:00 pm et to report its first quarter 2022 financial results and provide a corporate update.
FATE Ratings Summary
FATE Quant Ranking